{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:32:27Z","timestamp":1777984347300,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Health"],"DOI":"10.1186\/s12978-026-02305-0","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T11:20:09Z","timestamp":1774524009000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Self-managed medical abortion in Nigeria: a prospective, comparative study of clinical outcomes for a misoprostol-alone regimen obtained from patent medicine vendors compared to clinics"],"prefix":"10.1186","volume":"23","author":[{"given":"Kristen M.","family":"Shellenberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Storey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Risa","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nkiruka","family":"Okwesa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayodeji","family":"Oginni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Babtunde","family":"Adelekan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"issue":"1","key":"2305_CR1","doi-asserted-by":"publisher","first-page":"1758445","DOI":"10.1080\/26410397.2020.1758445","volume":"28","author":"OW Akande","year":"2020","unstructured":"Akande OW, Adenuga AT, Ejidike IC, Olufosoye AA. Unsafe abortion practices and the law in Nigeria: time for change. Sex Reprod Health Matters. 2020;28(1):1758445.","journal-title":"Sex Reprod Health Matters"},{"issue":"1","key":"2305_CR2","doi-asserted-by":"publisher","first-page":"e001814","DOI":"10.1136\/bmjgh-2019-001814","volume":"5","author":"SO Bell","year":"2020","unstructured":"Bell SO, Omoluabi E, OlaOlorun F, Shankar M, Moreau C. Inequities in the incidence and safety of abortion in Nigeria. BMJ Glob Health. 2020;5(1):e001814.","journal-title":"BMJ Glob Health"},{"issue":"7","key":"2305_CR3","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1080\/01443615.2017.1421622","volume":"38","author":"FM Akinlusi","year":"2018","unstructured":"Akinlusi FM, Rabiu KA, Adewunmi AA, Imosemi OD, Ottun TA, Badmus SA. Complicated unsafe abortion in a Nigerian teaching hospital: pattern of morbidity and mortality. J Obstet Gynaecol. 2018;38(7):961\u20136.","journal-title":"J Obstet Gynaecol"},{"issue":"1","key":"2305_CR4","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1186\/s12905-023-02464-3","volume":"23","author":"TO Oni","year":"2023","unstructured":"Oni TO, Adebowale SA, Afolabi AA, Akinyemi AI, Banjo OO. Perceived health facility-related barriers and post-abortion care-seeking intention among women of reproductive age in Osun state, Nigeria. BMC Womens Health. 2023;23(1):311.","journal-title":"BMC Womens Health"},{"issue":"3","key":"2305_CR5","doi-asserted-by":"publisher","first-page":"e0001862","DOI":"10.1371\/journal.pgph.0001862","volume":"4","author":"W Muga","year":"2024","unstructured":"Muga W, Juma K, Athero S, Kimemia G, Bangha M, Ouedraogo R. Barriers to post-abortion care service provision: a cross-sectional analysis in Burkina Faso, Kenya and Nigeria. PLOS Glob Public Health. 2024;4(3):e0001862.","journal-title":"PLOS Glob Public Health"},{"key":"2305_CR6","unstructured":"Abortion care guideline, second edition. Geneva: World Health Organization. 2024. Licence: CC BY-NC-SA 3.0 IGO."},{"issue":"1","key":"2305_CR7","doi-asserted-by":"publisher","first-page":"1829406","DOI":"10.1080\/26410397.2020.1829406","volume":"28","author":"RT Jayaweera","year":"2020","unstructured":"Jayaweera RT, Moseson H, Gerdts C. Misoprostol in the era of COVID-19: a love letter to the original medical abortion pill. Sex Reprod Health Matters. 2020;28(1):1829406.","journal-title":"Sex Reprod Health Matters"},{"issue":"Suppl 1","key":"2305_CR8","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12978-023-01574-3","volume":"20","author":"A Grossman","year":"2023","unstructured":"Grossman A, Prata N, Williams N, Ganatra B, Lavelanet A, L\u00e4ser L, et al. Availability of medical abortion medicines in eight countries: a descriptive analysis of key findings and opportunities. Reprod Health. 2023;20(Suppl 1):58.","journal-title":"Reprod Health"},{"key":"2305_CR9","doi-asserted-by":"publisher","first-page":"110132","DOI":"10.1016\/j.contraception.2023.110132","volume":"127","author":"EG Raymond","year":"2023","unstructured":"Raymond EG, Weaver MA, Shochet T. Effectiveness and safety of misoprostol-only for first-trimester medication abortion: an updated systematic review and meta-analysis. Contraception. 2023;127:110132.","journal-title":"Contraception"},{"issue":"12","key":"2305_CR10","doi-asserted-by":"publisher","first-page":"e0209415","DOI":"10.1371\/journal.pone.0209415","volume":"13","author":"FA Bello","year":"2018","unstructured":"Bello FA, Fawole B, Oluborode B, Awowole I, Irinyenikan T, Awonuga D, et al. Trends in misoprostol use and abortion complications: a cross-sectional study from nine referral hospitals in Nigeria. PLoS ONE. 2018;13(12):e0209415.","journal-title":"PLoS ONE"},{"issue":"1","key":"2305_CR11","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s12978-021-01290-w","volume":"18","author":"ME Byrne","year":"2021","unstructured":"Byrne ME, Omoluabi E, OlaOlorun FM, Moreau C, Bell SO. Determinants of women\u2019s preferred and actual abortion provision locations in Nigeria. Reprod Health. 2021;18(1):240.","journal-title":"Reprod Health"},{"key":"2305_CR12","doi-asserted-by":"publisher","first-page":"899662","DOI":"10.3389\/fgwh.2022.899662","volume":"3","author":"A Akinyemi","year":"2022","unstructured":"Akinyemi A, Owolabi OO, Erinfolami T, Stillman M, Bankole A. Quality of information offered to women by drug sellers providing medical abortion in Nigeria: evidence from providers and their clients. Front Glob Womens Health. 2022;3:899662.","journal-title":"Front Glob Womens Health"},{"issue":"1","key":"2305_CR13","doi-asserted-by":"publisher","first-page":"e0003971","DOI":"10.1371\/journal.pgph.0003971","volume":"5","author":"M Shankar","year":"2025","unstructured":"Shankar M, Omoluabi E, OlaOlorun FM, Khanna A, Ahmad D, Moreau C, et al. Quality of care offered by health care retail markets for medication abortion self-management: findings from states in Nigeria and India. PLOS Glob Public Health. 2025;5(1):e0003971.","journal-title":"PLOS Glob Public Health"},{"issue":"5","key":"2305_CR14","doi-asserted-by":"publisher","first-page":"e034670","DOI":"10.1136\/bmjopen-2019-034670","volume":"10","author":"M Stillman","year":"2020","unstructured":"Stillman M, Owolabi O, Fatusi AO, Akinyemi AI, Berry AL, Erinfolami TP, et al. Women\u2019s self-reported experiences using misoprostol obtained from drug sellers: a prospective cohort study in Lagos State, Nigeria. BMJ Open. 2020;10(5):e034670.","journal-title":"BMJ Open"},{"issue":"2","key":"2305_CR15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/sifp.12156","volume":"52","author":"H V\u00e4is\u00e4nen","year":"2021","unstructured":"V\u00e4is\u00e4nen H, Moore AM, Owolabi O, Stillman M, Fatusi A, Akinyemi A. Sexual and reproductive health literacy, misoprostol knowledge and use of medication abortion in Lagos State, Nigeria: a mixed methods study. Stud Fam Plann. 2021;52(2):217\u201337.","journal-title":"Stud Fam Plann"},{"issue":"10","key":"2305_CR16","doi-asserted-by":"publisher","first-page":"e0001139","DOI":"10.1371\/journal.pgph.0001139","volume":"2","author":"I Egwuatu","year":"2022","unstructured":"Egwuatu I, Nmezi S, Jayaweera R, Motana R, Grosso B, Kristianingrum IA, et al. Effectiveness of self-managed abortion during the COVID-19 pandemic: results from a pooled analysis of two prospective, observational cohort studies in Nigeria. PLOS Glob Public Health. 2022;2(10):e0001139.","journal-title":"PLOS Glob Public Health"},{"issue":"1","key":"2305_CR17","doi-asserted-by":"publisher","first-page":"e0191174","DOI":"10.1371\/journal.pone.0191174","volume":"13","author":"CH Rocca","year":"2018","unstructured":"Rocca CH, Puri M, Shrestha P, Blum M, Maharjan D, Grossman D, et al. Effectiveness and safety of early medication abortion provided in pharmacies by auxiliary nurse-midwives: a non-inferiority study in Nepal. PLoS ONE. 2018;13(1):e0191174.","journal-title":"PLoS ONE"},{"issue":"4","key":"2305_CR18","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1136\/bmjsrh-2022-201722","volume":"49","author":"N Kapp","year":"2023","unstructured":"Kapp N, Mao B, Menzel J, Eckersberger E, Saphonn V, Rathavy T, et al. A prospective, comparative study of clinical outcomes following clinic-based versus self-use of medical abortion. BMJ Sex Reprod Health. 2023;49(4):300\u20137.","journal-title":"BMJ Sex Reprod Health"},{"key":"2305_CR19","doi-asserted-by":"publisher","first-page":"110538","DOI":"10.1016\/j.contraception.2024.110538","volume":"140","author":"N Kapp","year":"2024","unstructured":"Kapp N, Bawah AA, Agula C, Menzel JL, Antobam SK, Asuming PO, et al. Medical abortion in Ghana: a non-randomized, non-inferiority study of access through pharmacies compared with clinics. Contraception. 2024;140:110538.","journal-title":"Contraception"},{"issue":"1","key":"2305_CR20","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2214-109X(21)00461-7","volume":"10","author":"H Moseson","year":"2022","unstructured":"Moseson H, Jayaweera R, Egwuatu I, Grosso B, Kristianingrum IA, Nmezi S, et al. Effectiveness of self-managed medication abortion with accompaniment support in Argentina and Nigeria (SAFE): a prospective, observational cohort study and non-inferiority analysis with historical controls. Lancet Glob Health. 2022;10(1):e105\u201313.","journal-title":"Lancet Glob Health"},{"issue":"9","key":"2305_CR21","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1111\/1471-0528.16668","volume":"128","author":"A Aiken","year":"2021","unstructured":"Aiken A, Lohr P, Lord J, Ghosh N, Starling J. Effectiveness, safety and acceptability of no-test medical abortion (termination of pregnancy) provided via telemedicine: a national cohort study. BJOG: Int J Obstet Gynecol. 2021;128(9):1464\u201374.","journal-title":"BJOG: Int J Obstet Gynecol"},{"issue":"1","key":"2305_CR22","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12874-016-0217-0","volume":"16","author":"C Pedroza","year":"2016","unstructured":"Pedroza C, Truong VT. Performance of models for estimating absolute risk difference in multicenter trials with binary outcome. BMC Med Res Methodol. 2016;16(1):113.","journal-title":"BMC Med Res Methodol"},{"key":"2305_CR23","unstructured":"StataCorp, Station C. TX: StataCorp LLC; 2019. (Stata Statistical Software)."},{"key":"2305_CR24","first-page":"18344","volume":"1471\u20130528","author":"N Kapp","year":"2025","unstructured":"Kapp N, Bawah AA, Mao B, Agula C, Menzel JL, Antobam SK, et al. Assessing information and counselling provision for medical abortion care in pharmacies versus clinics: secondary analysis of two non-inferiority cohort studies. BJOG. 2025;1471\u20130528:18344.","journal-title":"BJOG"},{"issue":"1","key":"2305_CR25","doi-asserted-by":"publisher","first-page":"102730","DOI":"10.1016\/j.jogc.2024.102730","volume":"47","author":"C Hunter","year":"2025","unstructured":"Hunter C, Burck M, Chambers C, Shawon F, Lavergne MR, Whitten A, et al. Test or no-test: comparison of medication abortion outcomes and adverse events when forgoing ultrasound, laboratory testing, and physical examination. J Obstet Gynaecol Can. 2025;47(1):102730.","journal-title":"J Obstet Gynaecol Can"}],"container-title":["Reproductive Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12978-026-02305-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12978-026-02305-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12978-026-02305-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T02:47:06Z","timestamp":1777949226000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12978-026-02305-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2305"],"URL":"https:\/\/doi.org\/10.1186\/s12978-026-02305-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7652351\/v1","asserted-by":"object"}]},"ISSN":["1742-4755"],"issn-type":[{"value":"1742-4755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]},"assertion":[{"value":"18 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The National Health Research Ethics Committee in Nigeria approved the research protocol for this study (NREC\/01\/010\/2007). All study participants provided informed consent and the research was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"93"}}